Refardt, Julie
Hofland, Johannes
Wild, Damian
Christ, Emanuel
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF320030_175544, SNF320030_152938.)
Universität Basel
Article History
Accepted: 5 April 2021
First Online: 4 November 2021
Declarations
:
: Julie Refardt declares that she has no conflict of interest. Johannes Hofland has received compensation from Ipsen and Novartis for service as a consultant. Damian Wild declares that he has no conflict of interest. Emanuel Christ declares that he has no conflict of interest.